Version 2.77

Description

Natalizumab is a humanized monoclonal antibody against the cellular adhesion molecule α4-integrin. Natalizumab is used in the treatment of multiple sclerosis and Crohn's disease. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood-brain barrier. Natalizumab has proven effective in treating the symptoms of both diseases, preventing relapse, vision loss, cognitive decline and significantly improving quality of life in people with multiple sclerosis, as well as increasing rates of remission and preventing relapse in Crohn's disease. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

Basic Part Properties

Part Display Name
Natalizumab
Part Type
Component (Describes the core component or analyte measured)
Created On
2007-07-17
Construct for LOINC Short Name
Natalizumab

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP64671-8

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 那他珠单抗
Synonyms: Natalizumab;Natalizumab 单抗;Tysabri;那他株单抗;那他珠单克隆抗体
fr-CA French (Canada) Natalizumab
et-EE Estonian (Estonia) Natalisumaab
es-ES Spanish (Spain) Natilizumab
it-IT Italian (Italy) Natalizumab
tr-TR Turkish (Turkey) Natalizumab
ru-RU Russian (Russian Federation) Натализумаб
nl-NL Dutch (Netherlands) natalizumab
fr-BE French (Belgium) Natalizumab